Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells
Fecha de publicación:
2014
Editorial:
Hindawi Publishing Corporation
Versión del editor:
Citación:
BioMed Research International, 2014 (2014); doi:10.1155/2014/265840
DOI:
Patrocinado por:
This work was supported by the Spanish grants of Fondo de Investigaciones Sanitarias (Instituto Carlos III) PS09/00420 and PI12/01280 and by the Celgene Corporation.
Colecciones
- Artículos [35233]
- Biología Funcional [741]
- Investigaciones y Documentos OpenAIRE [7668]
Ficheros en el ítem
![Thumbnail](/dspace/bitstream/handle/10651/42095/265840.pdf.jpg?sequence=5&isAllowed=y)